AFTC: Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT02818400
Collaborator
(none)
5
1
1
181
0

Study Details

Study Description

Brief Summary

In hindsight, the first "face graft" raises the fundamental problem of composite tissue allotransplantation (hand, larynx, abdominal wall, etc.) with the addition of specific technical and philosophical problems.

By proposing a prospective study concerning five new patients over the next three years, in the light of this first experience, the authors would like to confirm the surgical feasibility of this type of procedure, possibly extending it to other parts of the face (lateral third) and, like English and American teams, considering the possibility of total facial surface reconstruction.

In parallel, and while complying with the usual immunosuppression procedures, the deliberate choice of creating a microchimerism by the infusion of bone marrow stem cells (the origin and quantity of which will need to be determined) will be reaffirmed, in order to improve mucocutaneous tissue tolerance, while confirming the safety of this type of approach.

Five new cases will also provide observations for the many new fields of research developing around composite tissue transplants (neurophysiology, skin histopathology, psychiatry, haematology, immunology, etc.).

Condition or Disease Intervention/Treatment Phase
  • Procedure: composite tissue allotransplantation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation
Study Start Date :
Nov 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Composite tissue allotransplantation

Procedure: composite tissue allotransplantation

Outcome Measures

Primary Outcome Measures

  1. functional recovery : motor recovery [1 year]

    labial contact allowing complete mouth closure

  2. functional recovery : sensory recovery [1 year]

    Sensitivity to light touch, as assessed with the use of static monofilaments

  3. functional recovery : sensory recovery [1 year]

    sensitivity to heat and cold

Secondary Outcome Measures

  1. functional recovery : motor recovery [2 years, 5 years]

    labial contact allowing complete mouth closure

  2. functional recovery : sensory recovery [2 years, 5 years]

    Sensitivity to light touch, as assessed with the use of static monofilaments

  3. functional recovery : sensory recovery [2 years, 5 years]

    sensitivity to heat and cold

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with loss of unrepairable substance by conventional techniques shreds, at the front
Exclusion Criteria:
  • Facial lesions repaired by conventional reconstructive surgery techniques

  • History of malignancy in remission for less than 5 years

  • Malignant neoplasm undergoing changes

  • Severe psychiatric history

  • Patients above a score of 2 on the scale of the ASA (American Society of Anesthesiology)

  • Patients above a grade 1 in the classification NYHA ( New York Heart Association )

  • insufficient with renal creatinine clearance less than 70 mL / min or presence of a proteinuria

  • Severe hypertension

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Amiens France 80054

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens

Investigators

  • Principal Investigator: Bernard DEVAUCHELLE, Md, PhD, CHU Amiens

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT02818400
Other Study ID Numbers:
  • PHRCN06-PR-DEVAUCHELLE
First Posted:
Jun 29, 2016
Last Update Posted:
Aug 24, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Centre Hospitalier Universitaire, Amiens

Study Results

No Results Posted as of Aug 24, 2021